Ambroxol Hydrochloride and Glucose Injection

1 Pharmacological action This product has the characteristics of promoting mucus elimination and dissolving secretions. It can promote the elimination of viscous secretions in the respiratory tract and reduce mucus retention, thereby significantly promoting expectoration and improving respiratory conditions. When this product is used for treatment, the patient's mucus secretion can return to normal. Cough and sputum volume are usually significantly reduced, and the surfactant on the respiratory mucosa can thus play its normal protective function. 4 Toxicological action The toxicity index of ambroxol hydrochloride in acute toxicity tests is very low. Ames test and micronucleus test show that ambroxol hydrochloride is not mutagenic. Carcinogenicity studies in mice and rats show that ambroxol hydrochloride is not carcinogenic.

trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride

This product is a colorless or almost colorless clear liquid.

1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).

Slow intravenous drip. Adults and children over 12 years old: 2-3 times a day, 15 mg each time, severe cases can be increased to 30 mg each time. Children 6-12 years old: 2-3 times a day, 15 mg each time. Children 2-6 years old: 3 times a day, 7.5 mg each time. Children under 2 years old: 2 times a day, 7.5 mg each time. Treatment of infant respiratory distress syndrome (IRDS): The total daily dosage is 30 mg/kg calculated based on the infant's weight, divided into 4 doses, and should be administered using a syringe pump. The intravenous infusion time is at least 5 minutes. This product (pH 5.0) cannot be mixed with other solutions with a pH greater than 6.4, because the increase in pH will cause the free base of this product to precipitate.

This product is well tolerated, with occasional reports of mild upper gastrointestinal side effects, mainly heartburn, indigestion, and occasional nausea and vomiting. Allergic reactions rarely occur, mainly rashes, and severe acute allergic reactions have been reported in very few cases, but their relevance to ambroxol hydrochloride is not certain, and such patients are usually allergic to other substances.

Patients with known allergy to ambroxol hydrochloride or other ingredients of the formula are contraindicated.

Concurrent use with antibiotics such as amoxicillin, cefuroxime, erythromycin, and doxycycline may lead to increased antibiotic concentrations in lung tissue.

Store in an environment below 30℃. Tentatively 1 year

100ml: Ambroxol hydrochloride 15mg and glucose 5g